- melanin and skin pigmentation
- Bioactive Compounds and Antitumor Agents
- Laser Applications in Dentistry and Medicine
- Hepatitis Viruses Studies and Epidemiology
- Dermatologic Treatments and Research
- Skin Protection and Aging
- Phytochemical compounds biological activities
- Pharmacological Effects of Natural Compounds
- Viral Infections and Immunology Research
- Tattoo and Body Piercing Complications
- Systemic Lupus Erythematosus Research
Fudan University
2012-2025
Huashan Hospital
2024-2025
Shanghai Municipal Center For Disease Control Prevention
2012
ABSTRACT Background/Purpose Photobiomodulation (PBM) using light‐emitting diodes (LEDs) benefits tissue regeneration and wound healing. However, evidence regarding the efficacy of LED for post‐inflammatory erythema (PIE) hyperpigmentation (PIH) is limited. The aim this study was to explore effect medical (830 nm 590 nm) in prevention treatment PIE PIH. Methods vivo PIE/PIH model simplified pigmentation reaction after acute UVB exposure. 308 light (225 or 270 mJ/cm 2 ) induced on thigh ten...
ABSTRACT Childhood vitiligo, distinct from its adult counterpart, presents unique treatment challenges. Glycyrrhizin inhibits the release of high‐mobility group box 1 (HMGB1) protein keratinocytes, preventing melanocyte apoptosis and autophagy. Furthermore, orally administered compound glycyrrhizin (OCG) effectively treats various autoimmune disorders, demonstrating long‐term efficacy, safety, tolerability. This study compared efficacy OCG oral prednisone (OP), followed by phototherapy, in...
ABSTRACT Photobiomodulation (PBM) using 830 nm light‐emitting diode (LED) benefits tissue regeneration, wound healing and neural stimulation. However, there is not much exploration of its effect on melanocytes ex vivo skin model. This study aims to investigate the mechanism behind anti‐melanogenic activity LED provides evidence for in human Our results showed that at fluences ranging from 5 20 J/cm 2 inhibited melanosome maturation reduced melanin content, tyrosinase melanogenesis‐related...
SUMMARY This study aimed to determine current seroprevalence of hepatitis A virus (HAV) antibody in subjects aged 0–30 years Shanghai. total 5515 were recruited through random clustering sampling 2009. Basic clinical and demographic information records HAV vaccination acquired by questionnaire interviews review immunization records. Serum samples collected tested for anti-HAV IgM anti-HAV. The overall was 52·9%. Subjects 20–24 had the lowest (34·4%) seropositivity 5–9 highest (74·6%)...